Article
Polymorphisms in the methotrexate transport pathway: a new tool for MTX plasma level prediction in pediatric acute lymphoblastic leukemia.
Pharmacogenetics and genomics - 1 Feb 2013
Lopez-Lopez Elixabet, Ballesteros Javier, Piñan Maria A, Sanchez de Toledo José, Garcia de Andoin Nagore, Garcia-Miguel Purificacion, Navajas Aurora, Garcia-Orad Africa
Abstract excerpt
OBJECTIVES: Methotrexate (MTX) is an important component of therapy for pediatric acute lymphoblastic leukemia (ALL). Treatment with MTX often causes toxicity, which can necessitate dose reduction or treatment cessation. Interindividual differences in adverse reactions can be due to different factors, including polymorphisms in key genes. Recently, we confirmed the association between SLCO1B1 rs11045879...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
